Literature DB >> 11235949

Staged bilateral pallidotomy for treatment of Parkinson disease.

P M Intemann1, D Masterman, I Subramanian, A DeSalles, E Behnke, R Frysinger, J M Bronstein.   

Abstract

OBJECT: Several investigators have described the motor benefits derived from performing unilateral stereotactic pallidotomy for the treatment of Parkinson disease (PD), but little is known about the efficacy and complication rates of bilateral procedures. The goal of this study was to assess both these factors in 12 patients.
METHODS: Eleven patients with medically intractable PD underwent staged bilateral pallidotomy and one patient underwent a simultaneous bilateral procedure. Unilateral pallidotomy resulted in an improvement in the patients' Unified Parkinson Disease Rating Scale (UPDRS) total scores and motor subscores, Hoehn and Yahr stages, and Schwab and England Activities of Daily Living scores. There were no complications. The second procedures were performed 5 to 25 months after the first, and nearly complete 3-month follow-up data are available for eight of these patients. Staged bilateral pallidotomy did result in further improvements in some symptoms, but the patients proved to be less responsive to levodopa. In contrast to outcomes of the initial unilateral pallidotomy, there were significant complications. One patient suffered an acute stroke, two patients suffered delayed infarctions of the internal capsule, four patients had mild-to-moderate worsening of speech and increased drooling, and one patient complained of worsening memory.
CONCLUSIONS: Bilateral pallidotomy results in modest benefits but is associated with an increased risk of complications.

Entities:  

Mesh:

Year:  2001        PMID: 11235949     DOI: 10.3171/jns.2001.94.3.0437

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Focused Ultrasound: An Emerging Therapeutic Modality for Neurologic Disease.

Authors:  Paul S Fishman; Victor Frenkel
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

2.  Deep brain stimulation exacerbates hypokinetic dysarthria in a rat model of Parkinson's disease.

Authors:  Nathaniel O King; Collin J Anderson; Alan D Dorval
Journal:  J Neurosci Res       Date:  2015-10-26       Impact factor: 4.164

Review 3.  What happened to posteroventral pallidotomy for Parkinson's disease and dystonia?

Authors:  Robert E Gross
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

Review 4.  Deep brain stimulation for movement disorders.

Authors:  Paul S Larson
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

5.  Bilateral MR-Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson's Disease With 1-Year Follow-Up.

Authors:  Marc N Gallay; David Moser; Anouk E Magara; Fabio Haufler; Daniel Jeanmonod
Journal:  Front Neurol       Date:  2021-02-09       Impact factor: 4.003

6.  Stereotactic Surgery for Treating Intractable Tourette Syndrome: A Single-Center Pilot Study.

Authors:  Xin Wang; Liang Qu; Shunnan Ge; Nan Li; Jing Wang; Chun Qiu; Huijuan Kou; Jiaming Li; Jiangpeng Jing; Mingming Su; Zhaohui Zheng; Yang Li; Yan Qu; Xuelian Wang
Journal:  Brain Sci       Date:  2022-06-28

Review 7.  Surgical Treatment of Parkinson's Disease: Devices and Lesion Approaches.

Authors:  Vibhash D Sharma; Margi Patel; Svjetlana Miocinovic
Journal:  Neurotherapeutics       Date:  2020-10-28       Impact factor: 7.620

Review 8.  Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?

Authors:  Jean-François Daneault; Benoit Carignan; Abbas F Sadikot; Michel Panisset; Christian Duval
Journal:  BMC Med       Date:  2013-03-20       Impact factor: 8.775

Review 9.  Surgical treatment of dyskinesia in Parkinson's disease.

Authors:  Renato P Munhoz; Antonio Cerasa; Michael S Okun
Journal:  Front Neurol       Date:  2014-04-29       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.